Steriflow Limited - Limited company - abbreviated - 11.6

Steriflow Limited - Limited company - abbreviated - 11.6


07557631 1.4.13 31.3.14 31.3.14 Company accounts Private Limited Company FY true false true false true false false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure075576312013-03-31075576312014-03-31075576312013-04-012014-03-31075576312012-03-31075576312012-04-012013-03-31075576312013-03-3107557631ns12:England2013-04-012014-03-3107557631ns14:PoundSterling2013-04-012014-03-3107557631ns7:Director12013-04-012014-03-3107557631ns7:OrdinaryShareClass12013-04-012014-03-3107557631ns7:Director22013-04-012014-03-3107557631ns7:RegisteredOffice2013-04-012014-03-3107557631ns7:EntityAccountantsOrAuditors2013-04-012014-03-3107557631ns5:PatentsConcessionsLicencesTradeMarksSimilar2013-04-012014-03-3107557631ns7:OrdinaryShareClass12014-03-3107557631ns7:OrdinaryShareClass12013-03-31
REGISTERED NUMBER: 07557631 (England and Wales)















ABBREVIATED UNAUDITED ACCOUNTS

FOR THE YEAR ENDED 31 MARCH 2014

FOR

STERIFLOW LIMITED

STERIFLOW LIMITED (REGISTERED NUMBER: 07557631)






CONTENTS OF THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2014




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

STERIFLOW LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2014







DIRECTORS: S M Gordon
M Snowball





REGISTERED OFFICE: 7 Billing Road
Northampton
NN1 5AN





REGISTERED NUMBER: 07557631 (England and Wales)





ACCOUNTANTS: Cochran, Harris & Clarke Limited
7 Billing Road
Northampton
Northamptonshire
NN1 5AN

STERIFLOW LIMITED (REGISTERED NUMBER: 07557631)

ABBREVIATED BALANCE SHEET
31 MARCH 2014

2014 2013
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 2 2,600 3,640

CURRENT ASSETS
Debtors 5,708 1,764
Cash at bank 2,979 118
8,687 1,882
CREDITORS
Amounts falling due within one year 92,251 52,364
NET CURRENT LIABILITIES (83,564 ) (50,482 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(80,964
)
(46,842
)

CAPITAL AND RESERVES
Called up share capital 3 10,000 10,000
Profit and loss account (90,964 ) (56,842 )
SHAREHOLDERS' FUNDS (80,964 ) (46,842 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2014 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 15 December 2014 and were signed on its behalf
by:





M Snowball - Director


STERIFLOW LIMITED (REGISTERED NUMBER: 07557631)

NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2014

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared on a going concern basis which is dependant upon the continued
support of the shareholders.

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Intangible assets
Patents purchased by the company are amortised individually over their anticipated economic life. The
anticipated economic life of the existing purchased patent is five years.

Applications for patents resulting from research and development expenditure is written off unless the patent has
a readily ascertainable market value in accordance with accounting standard FRS10.

Deferred tax
Deferred tax is recognised in respect of all material timing differences that have originated but not reversed at the
balance sheet date. Deferred tax assets arising from trading losses are not recognised until the utilisation of these
losses can be foreseen with greater certainty.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


2. INTANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2013
and 31 March 2014 5,200
AMORTISATION
At 1 April 2013 1,560
Amortisation for year 1,040
At 31 March 2014 2,600
NET BOOK VALUE

At 31 March 2014 2,600
At 31 March 2013 3,640

3. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2014 2013
value: £    £   
10,000 Ordinary £1 10,000 10,000